Login Register
English
0

Cart

$ 0

Lunatic Fringe Polyclonal Antibody

Lunatic Fringe Polyclonal Antibody

Views(5) Publications(0) Catalog no(ABP55104)
Datasheet Print Share Email Share
  • Specification
  • FAQ
  • Publications(0)
  • Comments(0)

Specification

Product name Lunatic Fringe Polyclonal Antibody
Immunogen Synthesized peptide derived from the Internal region of human Lunatic Fringe at AA rangle: 90-170
Host Rabbit
Reactivity Human,Mouse,Rat
Applications WB,ELISA
Applications notes Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000;ELISA 1:10000;Not yet tested in other applications.
Clonality Polyclonal
Preparation method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Alternative LFNG; Beta-1; 3-N-acetylglucosaminyltransferase lunatic fringe; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase

Product Properties

Formulation Liquid solution
Concentration 1 mg/ml
Molecular weight 42kD
Storage buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Storage instructions Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Shipping Gel pack with blue ice.
Precautions The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Additional Information

Background LFNG is a member of the fringe gene family which also includes radical and manic fringe genes. They all encode evolutionarily conserved glycosyltransferases that act in the Notch signaling pathway to define boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, fringe proteins have a fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling. This gene product is predicted to be a single-pass type II Golgi membrane protein but it may also be secreted and proteolytically processed like the related proteins in mouse and Drosophila (PMID: 9187150). Mutations in this gene have been associated with autosomal recessive spondylocostal dysostosis 3. Multiple transcript variants encoding different isoforms have been found for this gene.
Gene ID 3955
Alternative LFNG; Beta-1; 3-N-acetylglucosaminyltransferase lunatic fringe; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
Others Lunatic Fringe Polyclonal Antibody detects endogenous levels of Lunatic Fringe protein.
Accession Q8NES3
Observed Band(KD) 42

Image & description

Fig. Western Blot analysis of 3T3 cells using Lunatic Fringe Polyclonal Antibody diluted at 1:1000.

Fig. Western Blot analysis of 3T3 cells using Lunatic Fringe Polyclonal Antibody diluted at 1:1000.

This product has been cited in0publications

Reviews

There are no reviews yet.

Be the first to review “Lunatic Fringe Polyclonal Antibody”